0001179110-20-011522.txt : 20201202 0001179110-20-011522.hdr.sgml : 20201202 20201202062352 ACCESSION NUMBER: 0001179110-20-011522 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201130 FILED AS OF DATE: 20201202 DATE AS OF CHANGE: 20201202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Carmona Jose CENTRAL INDEX KEY: 0001693612 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38586 FILM NUMBER: 201362352 MAIL ADDRESS: STREET 1: C/O INNOCOLL HOLDINGS PLC STREET 2: 3803 WEST CHESTER PIKE CITY: NEWTOWN SQUARE STATE: PA ZIP: 19073 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rubius Therapeutics, Inc. CENTRAL INDEX KEY: 0001709401 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042688109 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 399 BINNEY STREET, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-679-9600 MAIL ADDRESS: STREET 1: 399 BINNEY STREET, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2020-11-30 0 0001709401 Rubius Therapeutics, Inc. RUBY 0001693612 Carmona Jose C/O RUBIUS THERAPEUTICS, INC. 399 BINNEY ST., SUITE 300 CAMBRIDGE MA 02139 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 6.27 2020-11-30 4 A 0 400000 0 A 2030-11-29 Common Stock 400000 400000 D 25% of this option shall vest on October 1, 2021, then in 12 equal quarterly installments thereafter. /s/ Joanne M. Protano, Attorney-in-Fact 2020-12-02